Skip to main content
ACON
NASDAQ Industrial Applications And Services

Aclarion Secures $10.4M Financing at Premium, Extends Cash Runway into 2028

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$4.19
Mkt Cap
$4.428M
52W Low
$4.052
52W High
$1,065.491
52W Position info
3.4% above low
Off High info
100% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

ACON is trading near its 52-week low of $4.052 (3.4% above the low).

Summary

Aclarion, Inc. closed a $10.4 million registered direct offering at a premium to its current stock price, significantly strengthening its balance sheet and extending its cash runway into 2028.


Key Events · Financing and Capital Events · ACON

  • Successful Capital Raise

    Aclarion closed a registered direct offering, raising $10.4 million through the sale of common stock and pre-funded warrants.

  • Premium Pricing

    The offering was priced at $5.18 per share, a notable premium compared to the current stock price of $4.19, demonstrating institutional confidence.

  • Extended Cash Runway

    The financing significantly strengthens the balance sheet, providing $21.6 million in cash, zero debt, and extending the company's operating runway into 2028.

  • De-risks Operations

    This capital infusion is critical for the micro-cap company, enabling continued execution of commercialization, evidence generation, and strategic partnerships.


Analysis · ACON · Industrial Applications And Services

This registered direct offering, while highly dilutive relative to the company's current valuation, is a critical financing event for Aclarion. The company successfully raised $10.4 million at a price of $5.18 per share, which is a significant premium to the current market price of $4.19. This capital infusion strengthens the balance sheet, providing $21.6 million in cash and eliminating debt, thereby extending the company's operating runway into 2028. For a micro-cap company trading near its 52-week low, securing such substantial funding at a premium de-risks its operations and provides crucial resources for advancing its Nociscan technology and achieving key milestones.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ACON was trading at $4.19 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.4M. The 52-week trading range was $4.05 to $1,065.49. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACON - Latest Insights

ACON
Aug 18, 2026, 8:30 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.71
Real-time Price: $2.38 info
Change: -$0.330 (-12%) info
Market Cap: $6.86M info
ACON
Aug 17, 2026, 8:30 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.46
Real-time Price: $2.38 info
Change: -$0.080 (-3%) info
Market Cap: $6.86M info
ACON
Aug 06, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.36
Real-time Price: $2.38 info
Change: +$0.020 (+0.85%) info
Market Cap: $6.86M info
ACON
Jun 09, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.35
Real-time Price: $2.38 info
Change: -$0.9656 (-29%) info
Market Cap: $6.86M info
ACON
Jun 08, 2026, 7:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $3.53
Real-time Price: $2.38 info
Change: -$1.15 (-33%) info
Market Cap: $6.86M info